SCHEMBL8423728

SCHEMBL8423728

Nc1nc2nc[nH]c2c(=O)n1CC(CO)CCO

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 4/20 0.38
PDE4B Q07343 4/20 0.38
PDE4C Q08493 4/20 0.38
PDE4D Q08499 4/20 0.38
ADORA2A P29274 5/20 0.38
ADORA2B P29275 5/20 0.38
PDE2A O00408 2/20 0.37
PDE1A P54750 2/20 0.37
PDE1B Q01064 2/20 0.37
PDE1C Q14123 2/20 0.37
PNP P00491 2/20 0.37
CFTR P13569 2/20 0.36
DPP4 P27487 1/20 0.35
PDE5A O76074 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
ADORA1 P30542 1/20 0.34
SCN1A P35498 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5664376 0.86 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL7442906 0.85 ADORA2A (0.41) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL7173171 0.84 ADORA2A (0.40) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL8362525 0.81 PNP (0.36) PDE4APDE4BPDE4CPDE4DADORA2B
SCHEMBL601906 0.81 PNP (0.34) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL27842808 0.80 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL28071828 0.80 PNP (0.45) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL8362387 0.80 PNP (0.36) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL5504400 0.79 ADORA2A (0.59) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL7617801 0.79 ADORA2A (0.40) PDE4APDE4BPDE4CPDE4DADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5958980-A TREATMENT OF CANCER BY ADMINISTERING TO THE MAMMAL IN NEED OF TREATMENT 4-(2-FORMYL-3-HYDROXYPHENOXYMETHYL)BENZOIC ACID OR A SALT, WHEREIN THE EFFECTIVE AMOUNT IS 50 TO 200 MG PER DAY WITHOUT SUBJECTING SAID MAMMAL TO RADIOTHERAPY DURING THE GLAXO WELLCOME, INC. (US) 1999-09-28 US disclosed
US-5872151-A ADMINISTERING TO AN IMMUNODEFICIENT PATIENT FOR TREATMENT OF VIRUS INFECTIONS AN IMMUNOPOTENTIATORY AMOUNT OF 4-(2-FORMYL-3-HYDROXYPHENOXYMETHYL)BENZOIC ACID OR SALTS GLAXO WELLCOME INC. (US) 1999-02-16 US disclosed